Cargando…
TP53TG1 enhances cisplatin sensitivity of non-small cell lung cancer cells through regulating miR-18a/PTEN axis
BACKGROUND: The acquisition of drug resistance has been considered as a main obstacle for cancer chemotherapy. Tumor protein 53 target gene 1 (TP53TG1), a p53-induced lncRNA, plays a vital role in the progression of human cancers. However, little is known about the detailed function and molecular me...
Autores principales: | Xiao, Huijuan, Liu, Yihe, Liang, Pan, Wang, Bo, Tan, Hongna, Zhang, Yonggao, Gao, Xianzheng, Gao, Jianbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863826/ https://www.ncbi.nlm.nih.gov/pubmed/29588850 http://dx.doi.org/10.1186/s13578-018-0221-7 |
Ejemplares similares
-
LncRNA MEG3 promotes cisplatin sensitivity of cervical cancer cells by regulating the miR-21/PTEN axis
por: Du, Ying, et al.
Publicado: (2022) -
Systematic analyses identify the anti-fibrotic role of lncRNA TP53TG1 in IPF
por: Sun, Jian, et al.
Publicado: (2022) -
Knockdown of lncRNA TP53TG1 Enhances the Efficacy of Sorafenib in Human Hepatocellular Carcinoma Cells
por: Lu, Qingchun, et al.
Publicado: (2022) -
The Role of TP53 in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors
por: Timmerman, Dennis M., et al.
Publicado: (2021) -
Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma
por: Wang, Jeffrey, et al.
Publicado: (2019)